Results 91 to 100 of about 27,895 (134)

Prophylactic Efficacy of CD388, a Novel Drug-Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study. [PDF]

Clin Infect Dis
Rojas RE, Equils O, Villacian J, Mann A, van Duijnhoven W, Vingerhoets J, Baguet T, Wang SS, Anandakumar A, Anger A, Tourneroche A, Silva IG, Flanagan S.   +12 more
europepmc   +1 more source

Humoral Correlates of Protection Against Influenza A/H3N2 Virus Infection. [PDF]

J Infect Dis
Hoy G, Stadlbauer D, Balmaseda A, Kuan G, López R, Carreno Quiroz JM, Ojeda S, Sánchez N, Yellin T, Plazaola M, Frutos A, Krammer F, Gordon A.   +12 more
europepmc   +1 more source

Phylogenetic Study of Local Patterns Influenza A(H3N2) Virus Transmission in a Semi-Isolated Population in a Remote Island in Japan Between 2011 and 2013. [PDF]

Influenza Other Respir Viruses
Han SM, Shiino T, Masuda S, Furuse Y, Yasaka T, Kanda S, Komori K, Saito N, Kubo Y, Smith C, Endo A, Robert A, Baguelin M, Ariyoshi K.   +13 more
europepmc   +1 more source

Local patterns of spread of influenza A H3N2 virus in coastal Kenya over a 1-year period revealed through virus sequence data. [PDF]

Sci Rep
Owuor DC, Ngoi JM, Nyasimi FM, Murunga N, Nyiro JU, Chaves SS, Nokes DJ, Agoti CN.   +7 more
europepmc   +1 more source

Corrigendum: The high-throughput solid-phase extraction of <i>cis</i>-cyclo(L-Leu-L-Pro) and <i>cis</i>-cyclo(L-Phe-L-Pro) from <i>Lactobacillus plantarum</i> demonstrates efficacy against multidrug-resistant bacteria and influenza A (H3N2) virus. [PDF]

Front Mol Biosci
Son J, Hong Y, Seong H, Oh YS, Kwak MK.
europepmc   +1 more source

Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019. [PDF]

Emerg Infect Dis, 2019
Takashita E, Ichikawa M, Morita H, Ogawa R, Fujisaki S, Shirakura M, Miura H, Nakamura K, Kishida N, Kuwahara T, Sugawara H, Sato A, Akimoto M, Mitamura K, Abe T, Yamazaki M, Watanabe S, Hasegawa H, Odagiri T.   +18 more
europepmc   +1 more source

The high-throughput solid-phase extraction of <i>cis</i>-cyclo(L-Leu-L-Pro) and <i>cis</i>-cyclo(L-Phe-L-Pro) from <i>Lactobacillus plantarum</i> demonstrates efficacy against multidrug-resistant bacteria and influenza A (H3N2) virus. [PDF]

Front Mol Biosci
Son J, Hong Y, Seong H, Oh YS, Kwak MK.
europepmc   +1 more source

A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model. [PDF]

Clin Infect Dis, 2019
Han A, Czajkowski LM, Donaldson A, Baus HA, Reed SM, Athota RS, Bristol T, Rosas LA, Cervantes-Medina A, Taubenberger JK, Memoli MJ.   +10 more
europepmc   +1 more source

Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K. [PDF]

NPJ Vaccines
Moor N, Chen N, Behrens GMN, Zhang L, Moldenhauer AS, Winkler M, Happle C, Steffens S, Stankov MV, Lürken K, Pöhlmann S, Hoffmann M.   +11 more
europepmc   +1 more source

Exposure of dogs to influenza A and B viruses. [PDF]

One Health
Trombetta CM, Marotta MG, Marchi S, Bonfante F, Maniero S, Napolitan A, Moreno A, Chiapponi C, Temperton N, Scott S, Daly JM, Manenti A, Montomoli E, Lanave G, Camero M, Martella V.   +15 more
europepmc   +1 more source